Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Current Oncology Reports|October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung CancerGiuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.
Cancer|June 29, 2023
Allocation of authorship and patient enrollment among global clinical trials in oncologyFidel Rubagumya, Adam Fundytus, Sophie Keith-Brown, et al.
The Lancet. Global Health|October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forwardKristina Jenei, Zeba Aziz, Christopher Booth, et al.
Journal of the National Cancer Institute|April 6, 2026
Common sense oncology values to action: a patient led framework for randomized clinical trial designMichelle L Tregear, Haydeé C Verduzco-Aguirre, Brian Shkabari, et al.
Cancer Biology & Therapy|February 3, 2005
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune responseAnna Carbone, Ulrich Rodeck, Francesco Angelo Mauri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2025
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)Alfredo Addeo, Daniel Dietrich, Nicolas Mach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.
Cancer Treatment Reviews|January 3, 2026
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?Seng Wee Cheo, Molly S C Li, Derek De-Rui Huang, et al.
Cancer Treatment Reviews|February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the targetGiannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Frontiers in Oncology|September 25, 2020
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer PatientsChristian Britschgi, Alfredo Addeo, Markus Rechsteiner, et al.
Pageof 37